window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : September 24, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Therapeutic Areas

  • Clinical & Regulatory,Digital & Data,Therapeutic Areas

    Scotland launches accredited Alzheimer’s biomarker testing service

    Scottish Brain Sciences (SBS) has launched an accredited laboratory service [...]

    June 6, 2026
  • Biotech & Pharma Business,Clinical & Regulatory,Pharmaceuticals and therapeutics,Therapeutic Areas

    Pierre Fabre moves closer to first-line approval for BRAFTOVI in BRAF-mutant metastatic colorectal cancer

    Pierre Fabre Laboratories has received a positive opinion from the [...]

    June 6, 2026
  • Advanced Therapies,Drug Discovery & Development,Pharmaceuticals and therapeutics,Therapeutic Areas

    Skyhawk reports encouraging 12-month Huntington’s disease data for SKY-0515

    Skyhawk Therapeutics has reported encouraging 12-month results from its ongoing [...]

    June 6, 2026
  • Clinical & Regulatory,Pharmaceuticals and therapeutics,Therapeutic Areas

    NICE backs serplulimab for extensive-stage small cell lung cancer

    People with extensive-stage small cell lung cancer in England and [...]

    June 6, 2026
  • Clinical & Regulatory,Therapeutic Areas

    Baptist Health and START expand access to early-phase cancer trials in South Florida

    Patients across South Florida are set to gain greater access [...]

    June 6, 2026
  • Central Nervous System,Digital & Data,Drug Delivery & Formulation,Drug Discovery & Development,Therapeutic Areas

    Bonito Biosciences partners with DaltonTx on AI-driven RNA delivery research

    Bonito Biosciences has entered a collaboration with DaltonTx to develop [...]

    June 6, 2026
  • Biotech & Pharma Business,Clinical & Regulatory,Pharmaceuticals and therapeutics,Therapeutic Areas

    Mestag Therapeutics doses first patient in Phase 1 STARLYS solid tumour trial

    Mestag Therapeutics has dosed the first patient in its Phase [...]

    May 28, 2026
  • Clinical & Regulatory,Digital & Data,Therapeutic Areas

    Grow Therapy study finds most patients report meaningful improvement in depression and anxiety symptoms

    Grow Therapy has published its first peer-reviewed outcomes study, reporting [...]

    May 14, 2026
  • Biotech & Pharma Business,Drug Discovery & Development,Pharmaceuticals and therapeutics,Therapeutic Areas

    EPIK Biosciences launches with ketamine pipeline targeting mental health, chronic pain and addiction

    EPIK Biosciences has launched as a new psychedelic drug development [...]

    May 14, 2026
  • Biotech & Pharma Business,Clinical & Regulatory,Drug Discovery & Development,Therapeutic Areas

    Incannex links PSX-001 psilocybin programme to White House push on psychedelic mental health treatments

    Incannex Healthcare has said its PSX-001 oral synthetic psilocybin programme [...]

    May 14, 2026
Previous151617Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Brainomix to present five ILD studies on quantitative CT at ERS Congress
    Categories: Advanced Therapies, Clinical & Regulatory, Digital & Data, Research & Development, Therapeutic Areas
  • Genespire starts international MMA study to support GENE202 development
    Categories: Advanced Therapies, Clinical & Regulatory, Drug Discovery & Development, Pharmaceuticals and therapeutics, Research & Development
  • Insilico launches open consortium to assess AI drug discovery benchmarks
    Categories: Digital & Data, Drug Discovery & Development, Research & Development
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details.
OK
Go to Top